Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
Open Access
- 30 April 2015
- journal article
- review article
- Published by Hindawi Limited in Journal of Diabetes Research
- Vol. 2015, 1-16
- https://doi.org/10.1155/2015/697010
Abstract
Diabetes is a worldwide epidemic that has led to a rise in diabetic kidney disease (DKD). Over the past two decades, there has been significant clarification of the various pathways implicated in the pathogenesis of DKD. Nonetheless, very little has changed in the way clinicians manage patients with this disorder. Indeed, treatment is primarily centered on controlling hyperglycemia and hypertension and inhibiting the renin-angiotensin system. The purpose of this review is to describe the current understanding of how the hemodynamic, metabolic, inflammatory, and alternative pathways are all entangled in pathogenesis of DKD and detail the various therapeutic targets that may one day play a role in quelling this epidemic.Keywords
This publication has 143 references indexed in Scilit:
- Effect of Thiazolidinedione Treatment on Proteinuria and Renal Hemodynamic in Type 2 Diabetic Patients with Overt NephropathyHormone and Metabolic Research, 2012
- Autophagy and the Integrated Stress ResponseMolecular Cell, 2010
- Avosentan for Overt Diabetic NephropathyJournal of the American Society of Nephrology, 2010
- Pirfenidone Is Renoprotective in Diabetic Kidney DiseaseJournal of the American Society of Nephrology, 2009
- Autophagy regulates lipid metabolismNature, 2009
- Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?Journal of Cell Communication and Signaling, 2009
- The Natural Course of Microalbuminuria among African Americans with Type 2 Diabetes: A 3-Year StudyThe American Journal of Medicine, 2009
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2008
- Rhein reverses the diabetic phenotype of mesangial cells over‐expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathwayBritish Journal of Pharmacology, 2008
- The Role of Inflammatory Cytokines in Diabetic NephropathyJournal of the American Society of Nephrology, 2008